These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32893078)

  • 1. Dominant SCN2A mutation with variable phenotype in two generations.
    Passi GR; Mohammad SS
    Brain Dev; 2021 Jan; 43(1):166-169. PubMed ID: 32893078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum.
    Suddaby JS; Silver J; So J
    Psychiatr Genet; 2019 Jun; 29(3):91-94. PubMed ID: 30741786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.
    Schwarz N; Hahn A; Bast T; Müller S; Löffler H; Maljevic S; Gaily E; Prehl I; Biskup S; Joensuu T; Lehesjoki AE; Neubauer BA; Lerche H; Hedrich UBS
    J Neurol; 2016 Feb; 263(2):334-343. PubMed ID: 26645390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in Understanding and Treating SCN2A-Mediated Disorders.
    Sanders SJ; Campbell AJ; Cottrell JR; Moller RS; Wagner FF; Auldridge AL; Bernier RA; Catterall WA; Chung WK; Empfield JR; George AL; Hipp JF; Khwaja O; Kiskinis E; Lal D; Malhotra D; Millichap JJ; Otis TS; Petrou S; Pitt G; Schust LF; Taylor CM; Tjernagel J; Spiro JE; Bender KJ
    Trends Neurosci; 2018 Jul; 41(7):442-456. PubMed ID: 29691040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotypic spectrum of SCN2A-related epilepsy.
    Reynolds C; King MD; Gorman KM
    Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic spectrum of SCN2A-associated episodic ataxia.
    Schwarz N; Bast T; Gaily E; Golla G; Gorman KM; Griffiths LR; Hahn A; Hukin J; King M; Korff C; Miranda MJ; Møller RS; Neubauer B; Smith RA; Smol T; Striano P; Stroud B; Vaccarezza M; Kluger G; Lerche H; Fazeli W
    Eur J Paediatr Neurol; 2019 May; 23(3):438-447. PubMed ID: 30928199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episodic ataxia associated with a de novo SCN2A mutation.
    Leach EL; van Karnebeek CD; Townsend KN; Tarailo-Graovac M; Hukin J; Gibson WT
    Eur J Paediatr Neurol; 2016 Sep; 20(5):772-6. PubMed ID: 27328862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
    Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development.
    Fazeli W; Becker K; Herkenrath P; Düchting C; Körber F; Landgraf P; Nürnberg P; Altmüller J; Thiele H; Koy A; Liebau MC; Simon T; Dötsch J; Cirak S
    Neuropediatrics; 2018 Dec; 49(6):379-384. PubMed ID: 30165711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Exome Sequencing Implicates
    Maksemous N; Smith RA; Sutherland HG; Sampaio H; Griffiths LR
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review.
    Mangano GD; Fontana A; Antona V; Salpietro V; Mangano GR; Giuffrè M; Nardello R
    Mol Genet Genomic Med; 2022 May; 10(5):e1911. PubMed ID: 35348308
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yang XR; Ginjupalli VKM; Theriault O; Poulin H; Appendino JP; Au PYB; Chahine M
    J Neurophysiol; 2022 May; 127(5):1388-1397. PubMed ID: 35417276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
    Wolff M; Brunklaus A; Zuberi SM
    Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia].
    Guan J; Du KX; Dong Y; Li L; Song PP; Gong H; Zhang XL; Jia TM
    Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):51-55. PubMed ID: 34986624
    [No Abstract]   [Full Text] [Related]  

  • 15. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
    Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
    Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.
    Liao Y; Anttonen AK; Liukkonen E; Gaily E; Maljevic S; Schubert S; Bellan-Koch A; Petrou S; Ahonen VE; Lerche H; Lehesjoki AE
    Neurology; 2010 Oct; 75(16):1454-8. PubMed ID: 20956790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo SCN2A splice site mutation in a boy with Autism spectrum disorder.
    Tavassoli T; Kolevzon A; Wang AT; Curchack-Lichtin J; Halpern D; Schwartz L; Soffes S; Bush L; Grodberg D; Cai G; Buxbaum JD
    BMC Med Genet; 2014 Mar; 15():35. PubMed ID: 24650168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further delineation of phenotypic spectrum of SCN2A-related disorder.
    Richardson R; Baralle D; Bennett C; Briggs T; Bijlsma EK; Clayton-Smith J; Constantinou P; Foulds N; Jarvis J; Jewell R; Johnson DS; McEntagart M; Parker MJ; Radley JA; Robertson L; Ruivenkamp C; Rutten JW; Tellez J; Turnpenny PD; Wilson V; Wright M; Balasubramanian M
    Am J Med Genet A; 2022 Mar; 188(3):867-877. PubMed ID: 34894057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirming an expanded spectrum of SCN2A mutations: a case series.
    Matalon D; Goldberg E; Medne L; Marsh ED
    Epileptic Disord; 2014 Mar; 16(1):13-8. PubMed ID: 24659627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders.
    Berg AT; Thompson CH; Myers LS; Anderson E; Evans L; Kaiser AJE; Paltell K; Nili AN; DeKeyser JL; Abramova TV; Nesbitt G; Egan SM; Vanoye CG; George AL
    Brain; 2024 Aug; 147(8):2761-2774. PubMed ID: 38651838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.